Comment on: A rare case of eyelid sarcoidosis presenting as an orbital mass
Sir, With great interest, we read the article entitled, "A rare case of eyelid sarcoidosis presenting as an orbital mass" by Gaspar et al. [1] We have a few observations over which we request their comments.
The title of the article presents this case as an eyelid mass due to sarcoidosis whereas, in fact, the text describes it as an orbital mass seen through eyelid. The coronal contrast-enhanced computed tomography (CECT) demonstrates inferior extraconal orbital mass lesion. A sagittal section image would have been useful to evaluate extension of mass toward the lower eyelid. The intraoperative description also mentions the mass to be arising from orbital floor and not arising from lid tissues.
Sarcoidosis presenting as orbital mass is not uncommon. Orbital mass as presenting feature of sarcoidosis is found in up to 7% of patients. Orbital sarcoidosis commonly presents as palpable mass or as pseudotumor with inferior orbit being a common location of orbital sarcoidosis. [2, 3] Most sarcoid lesions are found in extraconal anterior orbital space, which makes the lesion easily palpable or visualized early through the lid. [3] Eyelid involvement is described in 12-17% cases of orbital sarcoidosis. [2, 3] We would like to know about the presence of any uveitis as the article fails to mention so. Uveitis is the most common finding of ocular sarcoidosis and has been demonstrated in 3-15% patients with orbital sarcoidosis. [2] [3] [4] Consistency of lesion or any change in lesion size with Valsalva has not been mentioned as the authors considered primary differential being orbital varix. CECT classically demonstrates hyperintense enhancement in case of varix with increase in size with post-Valsalva maneuver. In case thrombosed varix is suspected, magnetic resonance imaging with contrast and magnetic resonance angiography is a better imaging modality to differentiate vascular and nonvascular pathologies.
We would like to know whether systemic steroid treatment was initiated modality after histological diagnosis of sarcoidosis. We agree with their advice of close follow-up since patients with orbital lesions as a presenting feature of sarcoidosis may develop systemic sarcoidosis or may have further progression of existing systemic lesions. [5] Postsurgery clinical picture and radiological (CECT) images would have been helpful.
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1. The article does not mention any nonpharmacologic mean of managing vernal conjunctivitis apart from avoidance of allergen. Literature emphasizes the importance of avoidance of rubbing the eyes. It is known that rubbing causes histamine release, which further aggravates the condition [2] 2. The author has not mentioned washing face and eyes in the algorithm. Frequent washing of the face and eyes has been said to wash away the allergens, remove of cellular debris and toxic substances, and give symptomatic relief [3] 3. There is no emphasis on cold compression which enhances the effect of antihistaminics.
[4] It lowers the antigen-raised ocular surface temperature to less than the preexposure baseline and causes vasoconstriction, thus enhancing the local effect of drugs. VKC is often associated with ocular pruritus, and cold compresses give symptomatic relief in such cases [3] 4. Why did not the author specify use of preservative-free topical drops which reduce the risk of hypersensitivity to preservatives that are frequently superimposed in these patients 5. Why has the author highlighted the use of loteprednol over other steroids? It is said that fluorometholone is a more potent anti-inflammatory drug compared to loteprednol.
[5] Furthermore, fluorometholone has more efficacy in superficial ocular conditions while loteprednol is more efficacious in controlling intraocular conditions 6. What is the significance of lubricating eye drops in this condition? Their mechanism of action is same as that of washing eyes and face frequently along with cold compression. The patients already have a lot of watering, and there is no evidence of dry eye then how do we justify the use of artificial tears? 7. As per the algorithm, the author suggests that all the mentioned modes of treatment can be used in severe conditions. Does that mean we continue using antihistaminics in patients started with something as strong as tacrolimus? What is the treatment of choice to begin with in severe conditions according to the author? Can there be a more specific order of stepping up the treatment in severe conditions to make the article more pertinent?
